Intracoronary arterial retrograde thrombolysis with percutaneous coronary intervention: a novel use of thrombolytic to treat acute ST-segment elevation myocardial infarction.
Tian JW, Zhu M, Wang FQ, Li K, Zhou CF, Li B, Wang M, Deng JL, Jiang B, Bai J, Guo Y, Jin RJ, Zhang Z, Lin Y, Wang JH, Zhao SH, Shen MZ.
J Geriatr Cardiol. 2019 Jun;16(6):458-467. doi: 10.11909/j.issn.1671-5411.2019.06.004.
Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.
Kelly RV, Crouch E, Krumnacher H, Cohen MG, Stouffer GA.
Catheter Cardiovasc Interv. 2005 Nov;66(3):327-32. doi: 10.1002/ccd.20521.
Intracoronary injection of tirofiban prevents microcirculation dysfunction during delayed percutaneous coronary intervention in patients with acute myocardial infarction.
Sun Z, Zeng J, Huang H.
Int J Cardiol. 2016 Apr 1;208:137-40. doi: 10.1016/j.ijcard.2016.01.204. Epub 2016 Jan 23.
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction.
Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H.
Thromb Res. 2012 Nov;130(5):765-8. doi: 10.1016/j.thromres.2011.11.045. Epub 2011 Dec 20.
Myocardial imaging with thallium-201 for assessment of regional myocardial perfusion and viability after intracoronary thrombolytic therapy.
Beller GA.
Circulation. 1983 Aug;68(2 Pt 2):I70-6.
Intracoronary Versus Intravenous Low-Dose Tirofiban in Patients With ST-Elevation Myocardial Infarction: A Meta-Analysis of Randomised Controlled Trials.
Shi L, Chen L, Tian W, Zhao S.
Heart Lung Circ. 2024 Nov;33(11):1533-1542. doi: 10.1016/j.hlc.2024.05.006. Epub 2024 Jul 3.
Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.
Huikuri HV, Kervinen K, Niemelä M, Ylitalo K, Säily M, Koistinen P, Savolainen ER, Ukkonen H, Pietilä M, Airaksinen JK, Knuuti J, Mäkikallio TH; FINCELL Investigators.
Eur Heart J. 2008 Nov;29(22):2723-32. doi: 10.1093/eurheartj/ehn436. Epub 2008 Oct 9.
Efficacy and safety of intracoronary pro-urokinase injection during percutaneous coronary intervention in treating ST elevation myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials.
Yin XS, Huang YW, Li ZP, Dong JL, Zou JM, Tian L, Yang J.
Eur Rev Med Pharmacol Sci. 2022 Aug;26(16):5802-5813. doi: 10.26355/eurrev_202208_29518.
[Effect of intracoronary tirofiban combined with nitroprusside injection through thrombus aspiration catheter during primary percutaneous coronary intervention on acute anterior myocardial infarction patients with heavy thrombosis burden].
Zhang D, Wang L, Du J, Wang H, Xu L, Li W, Ni Z, Xia K, Liu Y, Yang X.
Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Jan;42(1):25-30.
National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease.
Harada M, Akimoto K, Ogawa S, Kato H, Nakamura Y, Hamaoka K, Saji T, Shimizu T, Kato T.
Pediatr Int. 2013 Dec;55(6):690-5. doi: 10.1111/ped.12187.
